1. Home /
  2. Drug Approvals

Drug Approvals

Merck's Stock Could Keep Climbing Higher

Here's what traders should do now.

Replimune Breaks Out: Could Rise 30% From Here

Let's check out the charts and indicators of this biotech name.

Is the Time Right to Buy Amgen After the Horizon Therapeutics Deal?

Here's the play traders can make.

Pacific Biosciences Has Made a Bottom Pattern: Prices to Watch

The stock bottomed in June/July and have worked higher.

BioVie Shares Higher on Alzheimer Data

Let's check the charts but be prepared for volatility.

Intra-Cellular Therapies Has My Attention

We have two price targets.

Biogen Surges on Alzheimer's Drug News: How to Play the Stock

Let's see how traders could react to the latest news.

So Much for a Red Wave, Crypto Rescue, Weighing Obesity Drugs, US-Taiwan Talk

Plus, the Treasury yield spread moved in the wrong direction Tuesday, signaling possible economic hardship ahead.

Aldeyra Therapeutics Is a Speculative Stock Worth a Small Position

Seasoned traders who understand risk could nibble on the long side of ALDX.

You Can Trade Lilly But Don't Act in Haste

One has to think that next year's earnings may get a little wonky.